Literature DB >> 20851806

Stereotactic body radiation therapy for spinal metastases.

Joana Cardia Lopes1, Arturo Navarro, Josep María Solé, Merche Martínez, Ferrán Guedea.   

Abstract

The goal of this paper is to expose the clinical results and review of the literature of the treatment of spinal metastases with Stereotactic Body Radiation Therapy (SBRT) presenting one case. A spinal metastases from rectal cancer treated with a single dose of 18Gy is presented. The following physics aspects are exposed: Treatment volume, tumor volume marginal doses and maximum doses in organs at risk. Clinical and radiographic follow up is presented. Local control and pain relief after one year of follow up was excellent. In properly selected patients, the treatment of limited metastatic disease with SBRT appears to be feasible and safe.

Entities:  

Mesh:

Year:  2010        PMID: 20851806     DOI: 10.1007/s12094-010-0570-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  9 in total

Review 1.  Solitary metastases: illusion versus reality.

Authors:  Philip Rubin; Ralph Brasacchio; Alan Katz
Journal:  Semin Radiat Oncol       Date:  2006-04       Impact factor: 5.934

2.  Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution.

Authors:  Peter C Gerszten; Steven A Burton; Cihat Ozhasoglu; William C Welch
Journal:  Spine (Phila Pa 1976)       Date:  2007-01-15       Impact factor: 3.468

3.  Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases.

Authors:  Arjun Sahgal; Christopher Ames; Dean Chou; Lijun Ma; Kim Huang; Wei Xu; Cynthia Chin; Vivan Weinberg; Cynthia Chuang; Phillip Weinstein; David A Larson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-12-25       Impact factor: 7.038

4.  Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.

Authors:  Farzan Siddiqui; Mehul Patel; Mumtaz Khan; Scott McLean; Jadranka Dragovic; Jian-Yue Jin; Benjamin Movsas; Samuel Ryu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-26       Impact factor: 7.038

5.  Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.

Authors:  Michael T Milano; Alan W Katz; Michael C Schell; Abraham Philip; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-19       Impact factor: 7.038

6.  Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure.

Authors:  Eric L Chang; Almon S Shiu; Ehud Mendel; Leni A Mathews; Anita Mahajan; Pamela K Allen; Jeffrey S Weinberg; Barry W Brown; Xin Shelly Wang; Shiao Y Woo; Charles Cleeland; Moshe H Maor; Laurence D Rhines
Journal:  J Neurosurg Spine       Date:  2007-08

7.  Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy.

Authors:  Michael T Milano; Hong Zhang; Su K Metcalfe; Ann G Muhs; Paul Okunieff
Journal:  Breast Cancer Res Treat       Date:  2008-08-22       Impact factor: 4.872

Review 8.  Stereotactic radiosurgery for spinal metastases: case report and review of treatment options.

Authors:  Sheema Chawla; Rami Abu-Aita; Abraham Philip; Tom Lundquist; Paul Okunieff; Michael T Milano
Journal:  Bone       Date:  2009-06-18       Impact factor: 4.398

9.  Stereotactic body radiotherapy for lesions of the spine and paraspinal regions.

Authors:  John W Nelson; David S Yoo; John H Sampson; Robert E Isaacs; Nicole A Larrier; Lawrence B Marks; Fang-Fang Yin; Q Jackie Wu; Zhiheng Wang; John P Kirkpatrick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-10       Impact factor: 7.038

  9 in total
  2 in total

1.  Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases.

Authors:  C V Sole; J L Lopez Guerra; R Matute; J Jaen; F Puebla; E Rivin; A Sanchez-Reyes; C Beltran; C Bourgier; F A Calvo; H Marsiglia
Journal:  Clin Transl Oncol       Date:  2012-11-10       Impact factor: 3.405

Review 2.  Oligometastasis and oligo-recurrence: more than a mirage.

Authors:  Fang Huang; Gang Wu; Kunyu Yang
Journal:  Radiat Oncol       Date:  2014-10-31       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.